[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Pages 60886-60887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-23972]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-day Comment Request; Quantification
of Behavioral and Physiological Effects of Drugs Using a Mobile
Scalable Device
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below. This proposed information
collection was previously published in the Federal Register on March
29, 2013, Vol.78, No.61, pages 19273-19274, and allowed 60-days for
public comment. No public comments were received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Institute on Drug Abuse (NIDA), the National Institutes of
Health, may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, [email protected] or by fax to 202-395-6974,
Attention: NIH Desk Officer.
DATES: Comments Due Date: Comments regarding this information
collection are best assured of having their full effect if received
within 30-days of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project contact: Dr. Steve
Gust, National Institute on Drug Abuse, 6001 Executive Blvd., Bethesda,
MD 20892, or call non-toll-free number (301) 443-6480 or Email your
request, including your address to: [email protected]. Formal requests
for additional plans and instruments must be requested in writing.
Proposed Collection: Quantification of Behavioral and Physiological
Effects of Drugs Using a Mobile Scalable Device, 0925-New, National
Institute on Drug Abuse (NIDA), National Institutes of Health (NIH).
Need and Use of Information Collection: This study will examine the
effectiveness of a mobile scalable device to detect the impairing
effects of different drugs. The primary purpose of the data collected
is to determine eligibility in a driving simulation study and to verify
the effectiveness of the experimental manipulations. The findings will
provide valuable information concerning the utility and effectiveness
of mobile, smartphone/tablet-based neurocognitive assessment that can
provide a multifactorial evaluation of cognitive functioning associated
with impaired driving.
OMB approval is requested for 18 months. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 859.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Type of Number of responses per per response Per annual
respondent respondents respondent (in hours) hour burden
----------------------------------------------------------------------------------------------------------------
Phone Screening............... Adults.......... 100 1 10/60 17
Consent Process, In-Person Adults.......... .............. .............. 45/60 75
Screening Adderall.
Consent Process, In-Person Adults.......... 100 .............. 45/60 75
Screening Xanax.
Consent Process, In-Person Adults.......... .............. .............. 45/60 75
Screening Cannabis.
Driving Survey................ Adults.......... .............. 1 15/60 18
Realism Survey................ Adults.......... .............. 1 3/60 4
Sleep and Intake Questionnaire Adults.......... .............. 2 3/60 7
Stanford Sleepiness Scale..... Adults.......... 72 6 1/60 7
Wellness Survey............... Adults.......... .............. 2 2/60 5
Dosing/Driving/Waiting........ Adults.......... .............. 2 4 576
----------------------------------------------------------------------------------------------------------------
[[Page 60887]]
Dated: September 25, 2013.
Glenda J. Conroy,
Executive Officer (OM Director), NIDA, NIH.
[FR Doc. 2013-23972 Filed 10-1-13; 8:45 am]
BILLING CODE 4140-01-P